GS
Gullapalli Srinivas
About Gullapalli Srinivas
Data last updated:
Gullapalli Srinivas is a Director at Genip Pharmaceuticals Private Limited (since 2012) and Director at Genip Formulations Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹6.93 Cr; the largest is Genip Pharmaceuticals Private Limited at ₹3.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genip Pharmaceuticals Private Limited U24100TG2012PTC079085 | Director | 10 Feb 2012 | 2012 | ₹3.50 Cr (FY 2025) | Active |
| Genip Formulations Private Limited U24290TG2022PTC161287 | Director | 05 Apr 2022 | 2022 | ₹3.44 Cr (FY 2025) | Active |
Board colleagues of Gullapalli Srinivas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gajawada Mahesh Kumar | 05128203 | Genip Pharmaceuticals Private Limited , Genip Formulations Private Limited | Director |
| Satyanarayana Dusari | 05190821 | Genip Pharmaceuticals Private Limited , Genip Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gullapalli Srinivas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gullapalli Srinivas
Gullapalli Srinivas currently holds 2 directorships: Genip Pharmaceuticals Private Limited (Director, since 10 Feb 2012, revenue ₹3.50 Cr (FY 2025)); Genip Formulations Private Limited (Director, since 05 Apr 2022, revenue ₹3.44 Cr (FY 2025)).
Gullapalli Srinivas was first appointed on 10 Feb 2012 as Director at Genip Pharmaceuticals Private Limited. The most recent appointment on record is 05 Apr 2022 at Genip Formulations Private Limited.
The 2 current companies of Gullapalli Srinivas that report revenue have a combined latest revenue of ₹6.93 Cr: Genip Pharmaceuticals Private Limited ₹3.50 Cr (FY 2025); Genip Formulations Private Limited ₹3.44 Cr (FY 2025).
The current boards of Gullapalli Srinivas's companies include Gajawada Mahesh Kumar (Genip Pharmaceuticals Private Limited), Satyanarayana Dusari (Genip Pharmaceuticals Private Limited).